Unilorin partners U.S. varsity on stem cell research

on   /   in News 8:00 am   /   Comments

unilorintinsProf. AbdulGaniyu Ambali, the Vice Chancellor of the University of Ilorin, said the institution was collaborating with the University of Wisconsin-Madison, U.S. on stem cell research.

This is contained in a statement signed by Mr Kunle Akogun, the Director, Corporate Affairs Unit of the University on Monday in Ilorin.

The statement said the vice chancellor was a one week visit to the University of Wisconsin-Madison, U.S.

It said that the collaboration with Wisconsin-Madison would afford the University a world class Stem Cell Research Laboratory.

It said Ambali visited the Chancellor of the University of Wisconsin-Madison, Prof. Rebecca Blank, and some world renowned experts on Stem Cell Research, including Prof. Su-Chun Zhang.

“The VC also met with other renowned stem cell researchers; Prof. Ralph Albrecht, Prof. Jeff Johnson and Prof. Tim Kamp,” it said.

“The VC had successfully secured commitment from the University of Wisconsin-Madison to partner UNILORIN and the university would ensure the structural development of the stem cell research centre.

“The VC had stressed the commitment of the University to the training of technical staff on stem cell research and related activities,” it said.

The statement noted that the University of Ilorin would be responsible for the provision of relevant regulations to support the development of the stem cell research centre.

It added that the university would also provide security and accommodation for all visiting staff of the University of Wisconsin-Madison after they arrived in Nigeria.

It noted that Ambali’s visit was in furtherance of the Federal Government’s mandate to the University as the only University designated in the North-central geopolitical zone for Bio-Technology research.

“The VC reiterated the resolve of the University to produce a critical mass of health professionals with competencies in management and control of common communicable and non-communicable diseases.

“We also want to translate research findings and generate funds through the commercialisation of key research outputs and foster national, regional and international linkages for collaborative research in partnership,’’ it said. (NAN)

    Print       Email